Dementia-Related Results of “Costs of Medication in Older Patients: Before and After Comprehensive Geriatric Assessment”

Abstract

Changes in the pharmacokinetics and pharmacodynamics of drugs in the presence of certain comorbidities and geriatric syndromes and reduced tolerability of potential drug side effects due to physiological changes with aging lead to difficulties in planning treatments in elderly adults, especially patients with dementia. The Comprehensive Geriatric Assessment has an important role in assessing polypharmacy and optimizing potentially inappropriate medications and potentially prescribing omissions in these patients. For this reason, we intend to reexamine our new study titled “Costs of medication in older patients: before and after comprehensive geriatric assessment,” because most of these results are also very important for dementia practice.